AssetID: 54478192
Headline: UNCAPTIONED: FDA Approves Non-Opioid Painkiller to Combat Addiction Crisis
Caption: FDA Approves Non-Opioid Painkiller to Combat Addiction Crisis. The US Food and Drug Administration (FDA) has approved Journavx, a new non-opioid painkiller for short-term pain in adults. Manufactured by Vertex Pharmaceuticals, Journavx works by targeting pain signals before they reach the brain, providing effective relief for moderate to severe pain without the addictive risks of opioids. The approval comes as the US continues to grapple with an opioid addiction crisis, declared a public health emergency in 2017. Clinical trials showed Journavx significantly reduced post-surgery pain with the FDA calling its approval "an important public health milestone in acute pain management”. Instructions: THIS VIDEO MUST NOT BE EDITED FOR LENGTH TO COMBINE WITH OTHER CONTENT
Keywords: Health & Wellbeing,US Food and Drug Administration,FDA,approved,Journavx,new,non-opiod,painkiller,short-term,pain,adults,block receptors,addictive,addiction,US,battle,manufactured,Vertex Pharmaceuticals,targeting,reach,provide,effective,relief
PersonInImage: